• Episode: 27 - Law to Biotech: Joseph La Barge on Starting a Company and the Future of Gene Therapy

  • Mar 26 2024
  • Length: 26 mins
  • Podcast

Episode: 27 - Law to Biotech: Joseph La Barge on Starting a Company and the Future of Gene Therapy

  • Summary

  • In this month’s episode of Trends from the Trenches, host Stan Gloss speaks with Joseph La Barge. La Barge trained as an attorney but has spent most of his career building biotech businesses and securing funding. He shepherded Spark Therapeutics through its acquisition by Roche and has since joined Apertura Gene Therapy as CEO. He and Stan talk about the entrepreneurship journey, gene expression and capsid engineering, and Apertura’s future goals and projects.

    Links from this episode:
    Bio-IT World
    BioTeam
    Bio-IT World Europe
    Apertura Gene Therapy

    Trends from the Trenches boiler: Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.

    Show more Show less

What listeners say about Episode: 27 - Law to Biotech: Joseph La Barge on Starting a Company and the Future of Gene Therapy

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.